The generic name of ganglioside is tetrahexose monosialic acid ganglioside sodium, and its action and efficacy is to promote neural remodeling, reduce nerve cell edema, and promote the recovery of the function of the injured central nervous system. Sodium tetrahexose ganglioside monosialate can promote neural remodeling, promote the recovery of the function of the central nervous system of the injury, can prevent secondary neurodegeneration after the injury, and can also reduce cellular edema by improving the activity of enzymes on the cell membrane. Clinically, it is mainly used in the treatment of vascular or traumatic central nervous system injury and Parkinson’s disease. It should be noted that the use of tetrahexose monosialate ganglioside sodium is prohibited in people who are allergic to any component of this drug, people with hereditary abnormalities of glucose-lipid metabolism, and patients with acute inflammatory demyelinating polyneuropathy. Some patients may experience adverse reactions such as chills, fever, malaise, diarrhea, palpitations, dyspnea, etc., which should be promptly informed to the doctor and treated accordingly. Tetrahexose monosialic acid ganglioside sodium should be used under the guidance of a professional doctor, and patients should not use the drug on their own, so as not to affect the condition or side effects.